查看購物車
  • Simplified Chinese
  • English
  • Japanese
維他命D檢驗的全球市場:各檢驗類型，各技術 - 產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)
市場調查報告書
商品編碼
1140628

維他命D檢驗的全球市場:各檢驗類型，各技術 - 產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)

Vitamin D Testing Market (Test Type: 25-Hydroxy D Vitamin, 1, 25-Dihydroxy D Vitamin; Technique: Radioimmunoassay, ELISA, HPLC, LC-MS, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 257 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球維他命D檢驗市場相關調查分析，提供市場趨勢，市場區隔分析，地區分析，企業簡介等資訊。

目錄

第1章 序文

第2章 前提與調查手法

第3章 摘要整理:全球維他命D檢驗市場

第4章 市場概要

  • 簡介
    • 產品定義
    • 產業的演進/發展
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球維他命D檢驗市場分析與預測(2017年～2031年)
    • 市場收益預測

第5章 主要考察

  • 主要的產業的發展
  • 維生素D缺乏症的盛行率
  • 醫療產業概要
  • 維他命D檢驗 - 產品生命週期
  • COVID-19影響的分析

第6章 全球維他命D檢驗市場分析與預測:各檢驗類型

  • 簡介和定義
  • 主要調查結果/發展
  • 市場金額的預測:各檢驗類型(2017年～2031年)
    • 羥基D維生素
    • 二羥基 D 維生素
  • 市場魅力:各檢驗類型

第7章 全球維他命D檢驗市場分析與預測:各終端用戶

  • 簡介和定義
  • 主要調查結果/發展
  • 市場金額的預測:各終端用戶(2017年～2031年)
    • 醫院
    • 診斷研究所
    • 居家照護
    • 照護現場
    • 其他
  • 市場魅力:各終端用戶

第8章 全球維他命D檢驗市場分析與預測:各技術

  • 簡介和定義
  • 主要調查結果/發展
  • 市場金額的預測:各技術(2017年～2031年)
    • 無線電免疫測量
    • ELISA
    • HPLC
    • LC-MS
    • 其他
  • 市場魅力:各技術

第9章 全球維他命D檢驗市場分析與預測:各患者類型

  • 簡介和定義
  • 主要調查結果/發展
  • 市場金額的預測:各患者類型(2017年～2031年)
    • 成人
    • 兒童
  • 市場魅力:各患者類型

第10章 全球維他命D檢驗市場分析與預測:各適應症

  • 簡介和定義
  • 主要調查結果/發展
  • 市場金額的預測:各適應症(2017年～2031年)
    • 骨質疏鬆症
    • 佝僂病
    • 甲狀腺疾病
    • 吸收不良
    • 維生素D缺乏症
    • 其他
  • 市場魅力:各適應症

第11章 全球維他命D檢驗市場分析與預測:各地區

  • 主要調查結果
  • 市場金額的預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力:各國各地區

第12章 北美的維他命D檢驗市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場金額的預測:各檢驗類型(2017年～2031年)
  • 市場金額的預測:各終端用戶(2017年～2031年)
  • 市場金額的預測:各技術(2017年～2031年)
  • 市場金額的預測:各患者類型(2017年～2031年)
  • 市場金額的預測:各適應症(2017年～2031年)
  • 市場金額的預測:各國(2017年～2031年)
    • 美國
    • 加拿大
  • 市場魅力分析

第13章 歐洲的維他命D檢驗市場分析與預測

第14章 亞太地區的維他命D檢驗市場分析與預測

第15章 南美的維他命D檢驗市場分析與預測

第16章 中東·非洲的維他命D檢驗市場分析與預測

第17章 競爭情形

  • 市場企業 - 競爭矩陣:階層·不同企業規模
  • 市場佔有率分析:各企業(2021年)
  • 企業簡介
    • DiaSorin SpA
    • DiaSys Diagnostic Systems GmbH
    • bioMerieux SA
    • Bio-Rad Laboratories
    • Abbott Laboratories
    • Siemens Healthineers
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific, Inc.
    • Quest Diagnostics Incorporated
    • Danaher Corporation
Product Code: TMRGL33557

The report provides revenue of the global vitamin D testing market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global vitamin D testing market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the vitamin D testing market.

The report delves into the competitive landscape of the global vitamin D testing market. Key players operating in the global vitamin D testing market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global vitamin D testing market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Vitamin D Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Vitamin D Testing Market Analysis and Forecast, 2017 - 2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Developments
  • 5.2. Vitamin D Deficiency Prevalence
  • 5.3. Healthcare Industry Overview
  • 5.4. Vitamin D Tests - Product Life Cycle
  • 5.5. Covid 19 Impact Analysis

6. Global Vitamin D Testing Market Analysis and Forecast, by Test Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Test Type, 2017 - 2031
    • 6.3.1. 25-Hydroxy D Vitamin
    • 6.3.2. 1,25- Dihydroxy D Vitamin
  • 6.4. Market Attractiveness, by Test Type

7. Global Vitamin D Testing Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017 - 2031
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Laboratories
    • 7.3.3. Home-care
    • 7.3.4. Point-of-care
    • 7.3.5. Others
  • 7.4. Market Attractiveness, by End-user

8. Global Vitamin D Testing Market Analysis and Forecast, by Technique

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Technique, 2017 - 2031
    • 8.3.1. Radioimmunoassay
    • 8.3.2. ELISA
    • 8.3.3. HPLC
    • 8.3.4. LC-MS
    • 8.3.5. Others
  • 8.4. Market Attractiveness, by Technique

9. Global Vitamin D Testing Market Analysis and Forecast, by Patient Type

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Patient Type, 2017 - 2031
    • 9.3.1. Adult
    • 9.3.2. Pediatric
  • 9.4. Market Attractiveness, by Patient Type

10. Global Vitamin D Testing Market Analysis and Forecast, by Indication

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast, by Indication, 2017 - 2031
    • 10.3.1. Osteoporosis
    • 10.3.2. Rickets
    • 10.3.3. Thyroid disorders
    • 10.3.4. Malabsorption
    • 10.3.5. Vitamin D Deficiency
    • 10.3.6. Others
  • 10.4. Market Attractiveness, by Indication

11. Global Vitamin D Testing Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Country/Region

12. North America Vitamin D Testing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Test Type, 2017 - 2031
    • 12.2.1. 25-Hydroxy D Vitamin
    • 12.2.2. 1,25- Dihydroxy D Vitamin
  • 12.3. Market Value Forecast, by End-user, 2017 - 2031
    • 12.3.1. Hospitals
    • 12.3.2. Diagnostic Laboratories
    • 12.3.3. Home-care
    • 12.3.4. Point-of-care
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Technique, 2017 - 2031
    • 12.4.1. Radioimmunoassay
    • 12.4.2. ELISA
    • 12.4.3. HPLC
    • 12.4.4. LC-MS
    • 12.4.5. Others
  • 12.5. Market Value Forecast, by Patient Type, 2017 - 2031
    • 12.5.1. Adult
    • 12.5.2. Pediatric
  • 12.6. Market Value Forecast, by Indication, 2017 - 2031
    • 12.6.1. Osteoporosis
    • 12.6.2. Rickets
    • 12.6.3. Thyroid disorders
    • 12.6.4. Malabsorption
    • 12.6.5. Vitamin D Deficiency
    • 12.6.6. Others
  • 12.7. Market Value Forecast, by Country, 2017 - 2031
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Test Type
    • 12.8.2. By End-user
    • 12.8.3. By Technique
    • 12.8.4. By Patient Type
    • 12.8.5. By Indication
    • 12.8.6. By Country

13. Europe Vitamin D Testing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Test Type, 2017 - 2031
    • 13.2.1. 25-Hydroxy D Vitamin
    • 13.2.2. 1,25- Dihydroxy D Vitamin
  • 13.3. Market Value Forecast, by End-user, 2017 - 2031
    • 13.3.1. Hospitals
    • 13.3.2. Diagnostic Laboratories
    • 13.3.3. Home-care
    • 13.3.4. Point-of-care
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Technique, 2017 - 2031
    • 13.4.1. Radioimmunoassay
    • 13.4.2. ELISA
    • 13.4.3. HPLC
    • 13.4.4. LC-MS
    • 13.4.5. Others
  • 13.5. Market Value Forecast, by Patient Type, 2017 - 2031
    • 13.5.1. Adult
    • 13.5.2. Pediatric
  • 13.6. Market Value Forecast, by Indication, 2017 - 2031
    • 13.6.1. Osteoporosis
    • 13.6.2. Rickets
    • 13.6.3. Thyroid disorders
    • 13.6.4. Malabsorption
    • 13.6.5. Vitamin D Deficiency
    • 13.6.6. Others
  • 13.7. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Spain
    • 13.7.5. Italy
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Test Type
    • 13.8.2. By End-user
    • 13.8.3. By Technique
    • 13.8.4. By Patient Type
    • 13.8.5. By Indication
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Vitamin D Testing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Test Type, 2017 - 2031
    • 14.2.1. 25-Hydroxy D Vitamin
    • 14.2.2. 1,25- Dihydroxy D Vitamin
  • 14.3. Market Value Forecast, by End-user, 2017 - 2031
    • 14.3.1. Hospitals
    • 14.3.2. Diagnostic Laboratories
    • 14.3.3. Home-care
    • 14.3.4. Point-of-care
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Technique, 2017 - 2031
    • 14.4.1. Radioimmunoassay
    • 14.4.2. ELISA
    • 14.4.3. HPLC
    • 14.4.4. LC-MS
    • 14.4.5. Others
  • 14.5. Market Value Forecast, by Patient Type, 2017 - 2031
    • 14.5.1. Adult
    • 14.5.2. Pediatric
  • 14.6. Market Value Forecast, by Indication, 2017 - 2031
    • 14.6.1. Osteoporosis
    • 14.6.2. Rickets
    • 14.6.3. Thyroid disorders
    • 14.6.4. Malabsorption
    • 14.6.5. Vitamin D Deficiency
    • 14.6.6. Others
  • 14.7. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Test Type
    • 14.8.2. By End-user
    • 14.8.3. By Technique
    • 14.8.4. By Patient Type
    • 14.8.5. By Indication
    • 14.8.6. By Country/Sub-region

15. Latin America Vitamin D Testing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Test Type, 2017 - 2031
    • 15.2.1. 25-Hydroxy D Vitamin
    • 15.2.2. 1,25- Dihydroxy D Vitamin
  • 15.3. Market Value Forecast, by End-user, 2017 - 2031
    • 15.3.1. Hospitals
    • 15.3.2. Diagnostic Laboratories
    • 15.3.3. Home-care
    • 15.3.4. Point-of-care
    • 15.3.5. Others
  • 15.4. Market Value Forecast, by Technique, 2017 - 2031
    • 15.4.1. Radioimmunoassay
    • 15.4.2. ELISA
    • 15.4.3. HPLC
    • 15.4.4. LC-MS
    • 15.4.5. Others
  • 15.5. Market Value Forecast, by Patient Type, 2017 - 2031
    • 15.5.1. Adult
    • 15.5.2. Pediatric
  • 15.6. Market Value Forecast, by Indication, 2017 - 2031
    • 15.6.1. Osteoporosis
    • 15.6.2. Rickets
    • 15.6.3. Thyroid disorders
    • 15.6.4. Malabsorption
    • 15.6.5. Vitamin D Deficiency
    • 15.6.6. Others
  • 15.7. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Test Type
    • 15.8.2. By End-user
    • 15.8.3. By Technique
    • 15.8.4. By Patient Type
    • 15.8.5. By Indication
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Vitamin D Testing Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Test Type, 2017 - 2031
    • 16.2.1. 25-Hydroxy D Vitamin
    • 16.2.2. 1,25- Dihydroxy D Vitamin
  • 16.3. Market Value Forecast, by End-user, 2017 - 2031
    • 16.3.1. Hospitals
    • 16.3.2. Diagnostic Laboratories
    • 16.3.3. Home-care
    • 16.3.4. Point-of-care
    • 16.3.5. Others
  • 16.4. Market Value Forecast, by Technique, 2017 - 2031
    • 16.4.1. Radioimmunoassay
    • 16.4.2. ELISA
    • 16.4.3. HPLC
    • 16.4.4. LC-MS
    • 16.4.5. Others
  • 16.5. Market Value Forecast, by Patient Type, 2017 - 2031
    • 16.5.1. Adult
    • 16.5.2. Pediatric
  • 16.6. Market Value Forecast, by Indication, 2017 - 2031
    • 16.6.1. Osteoporosis
    • 16.6.2. Rickets
    • 16.6.3. Thyroid disorders
    • 16.6.4. Malabsorption
    • 16.6.5. Vitamin D Deficiency
    • 16.6.6. Others
  • 16.7. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Test Type
    • 16.8.2. By End-user
    • 16.8.3. By Technique
    • 16.8.4. By Patient Type
    • 16.8.5. By Indication
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis, by Company (2021)
  • 17.3. Company Profiles
    • 17.3.1. DiaSorin S.p.A.
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Financial Analysis
      • 17.3.1.3. Growth Strategies
      • 17.3.1.4. SWOT Analysis
    • 17.3.2. DiaSys Diagnostic Systems GmbH
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Financial Analysis
      • 17.3.2.3. Growth Strategies
      • 17.3.2.4. SWOT Analysis
    • 17.3.3. bioMerieux SA
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Financial Analysis
      • 17.3.3.3. Growth Strategies
      • 17.3.3.4. SWOT Analysis
    • 17.3.4. Bio-Rad Laboratories
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Financial Analysis
      • 17.3.4.3. Growth Strategies
      • 17.3.4.4. SWOT Analysis
    • 17.3.5. Abbott Laboratories
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Financial Analysis
      • 17.3.5.3. Growth Strategies
      • 17.3.5.4. SWOT Analysis
    • 17.3.6. Siemens Healthineers
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Financial Analysis
      • 17.3.6.3. Growth Strategies
      • 17.3.6.4. SWOT Analysis
    • 17.3.7. F. Hoffmann-La Roche Ltd
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Financial Analysis
      • 17.3.7.3. Growth Strategies
      • 17.3.7.4. SWOT Analysis
    • 17.3.8. Thermo Fisher Scientific, Inc.
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Financial Analysis
      • 17.3.8.3. Growth Strategies
      • 17.3.8.4. SWOT Analysis
    • 17.3.9. Quest Diagnostics Incorporated
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Financial Analysis
      • 17.3.9.3. Growth Strategies
      • 17.3.9.4. SWOT Analysis
    • 17.3.10. Danaher Corporation
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Financial Analysis
      • 17.3.10.3. Growth Strategies
      • 17.3.10.4. SWOT Analysis

List of Tables

  • Table 01: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 02: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 03: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 04: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017-2031
  • Table 05: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Vitamin D Testing Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 09: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 10: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017-2031
  • Table 11: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 12: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 15: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 16: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017-2031
  • Table 17: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 18: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 21: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 22: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017-2031
  • Table 23: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 24: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 27: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 28: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017-2031
  • Table 29: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 30: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 33: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 34: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017-2031
  • Table 35: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 36: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Vitamin D Testing Market Snapshot
  • Figure 02: Global Vitamin D Testing Market Value (US$ Mn) and Distribution (%), by Region, 2021 and 2031
  • Figure 03: Global Vitamin D Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 04: Global Vitamin D Testing Market Value Share (%), by Test Type, 2021
  • Figure 05: Global Vitamin D Testing Market Value Share (%), by Technique, 2021
  • Figure 06: Global Vitamin D Testing Market Value Share (%), by Indication, 2021
  • Figure 07: Global Vitamin D Testing Market Value Share (%), by Patient Type, 2021
  • Figure 08: Global Vitamin D Testing Market Value Share (%), by End-user, 2021
  • Figure 09: Global Vitamin D Testing Market Value Share (%), by Region, 2021
  • Figure 10: Vitamin D Tests - Product Life Cycle
  • Figure 11: Vitamin D Testing Market - Key Industry Developments
  • Figure 12: Vitamin D Deficiency - Prevalence
  • Figure 13: Global Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2027
  • Figure 14: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by 25-Hydroxy D Vitamin, 2017-2031
  • Figure 15: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by 1,25-ihydroxy D Vitamin, 2017-2031
  • Figure 16: Global Vitamin D Testing Market Attractiveness, by Test Type, 2022-2031
  • Figure 17: Key Trends - Global Vitamin D Testing Market, by Test Type
  • Figure 18: Global Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2027
  • Figure 19: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Radioimmunoassay, 2017-2031
  • Figure 20: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by ELISA, 2017-2031
  • Figure 21: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by HPLC, 2017-2031
  • Figure 22: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by LC-MS, 2017-2031
  • Figure 23: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2031
  • Figure 24: Global Vitamin D Testing Market Attractiveness, by Technique, 2022-2031
  • Figure 25: Key Trends - Global Vitamin D Testing Market, by Technique
  • Figure 26: Global Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 27: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Osteoporosis, 2017-2031
  • Figure 28: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Rickets, 2017-2031
  • Figure 29: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Thyroid

Disorders, 2017-2031

  • Figure 30: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Malabsorption, 2017-2031
  • Figure 31: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Vitamin D Deficiency, 2017-2031
  • Figure 32: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2031
  • Figure 33: Global Vitamin D Testing Market Attractiveness, by Indication, 2022-2031
  • Figure 34: Key Trends - Global Vitamin D Testing Market, by Indication
  • Figure 35: Global Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
  • Figure 36: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Adult, 2017-2031
  • Figure 37: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pediatric, 2017-2031
  • Figure 38: Global Vitamin D Testing Market Attractiveness, by Patient Type, 2022-2031
  • Figure 39: Key Trends - Global Vitamin D Testing Market, by Patient Type
  • Figure 40: Global Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 41: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017-2031
  • Figure 42: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2017-2031
  • Figure 43: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Home Care, 2017-2031
  • Figure 44: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Point-of-care, 2017-2031
  • Figure 45: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2031
  • Figure 46: Global Vitamin D Testing Market Attractiveness, by End-user, 2022-2031
  • Figure 47: Key Trends - Global Vitamin D Testing Market, by End-user
  • Figure 48: Vitamin D Testing Market: Regional Outlook
  • Figure 49: Global Vitamin D Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 50: Global Vitamin D Testing Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 51: Global Vitamin D Testing Market Attractiveness, by Region, 2022-2031
  • Figure 52: North America Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 53: North America Vitamin D Testing Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 54: North America Vitamin D Testing Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 55: North America Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 56: North America Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2031
  • Figure 57: North America Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
  • Figure 58: North America Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 59: North America Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 60: North America Vitamin D Testing Market Attractiveness, by Test Type, 2022-2031
  • Figure 61: North America Vitamin D Testing Market Attractiveness, by Technique, 2022-2031
  • Figure 62: North America Vitamin D Testing Market Attractiveness, by Patient Type, 2022-2031
  • Figure 63: North America Vitamin D Testing Market Attractiveness, by Indication, 2022-2031
  • Figure 64: North America Vitamin D Testing Market Attractiveness, by End-user, 2022-2031
  • Figure 65: Europe Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 66: Europe Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 67: Europe Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 68: Europe Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 69: Europe Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2031
  • Figure 70: Europe Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
  • Figure 71: Europe Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 72: Europe Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 73: Europe Vitamin D Testing Market Attractiveness, by Test Type, 2022-2031
  • Figure 74: Europe Vitamin D Testing Market Attractiveness, by Technique, 2022-2031
  • Figure 75: Europe Vitamin D Testing Market Attractiveness, by Patient Type, 2022-2031
  • Figure 76: Europe Vitamin D Testing Market Attractiveness, by Indication, 2022-2031
  • Figure 77: Europe Vitamin D Testing Market Attractiveness, by End-user, 2022-2031
  • Figure 78: Asia Pacific Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 79: Asia Pacific Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 80: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 81: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 82: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2031
  • Figure 83: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
  • Figure 84: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 85: Asia Pacific Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 86: Asia Pacific Vitamin D Testing Market Attractiveness, by Test Type, 2022-2031
  • Figure 87: Asia Pacific Vitamin D Testing Market Attractiveness, by Technique, 2022-2031
  • Figure 88: Asia Pacific Vitamin D Testing Market Attractiveness, by Patient Type, 2022-2031
  • Figure 89: Asia Pacific Vitamin D Testing Market Attractiveness, by Indication, 2022-2031
  • Figure 90: Asia Pacific Vitamin D Testing Market Attractiveness, by End-user, 2022-2031
  • Figure 91: Latin America Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 92: Latin America Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 93: Latin America Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 94: Latin America Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 95: Latin America Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2031
  • Figure 96: Latin America Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
  • Figure 97: Latin America Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 98: Latin America Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 99: Latin America Vitamin D Testing Market Attractiveness, by Test Type, 2022-2031
  • Figure 100: Latin America Vitamin D Testing Market Attractiveness, by Technique, 2022-2031
  • Figure 101: Latin America Vitamin D Testing Market Attractiveness, by Patient Type, 2022-2031
  • Figure 102: Latin America Vitamin D Testing Market Attractiveness, by Indication, 2022-2031
  • Figure 103: Latin America Vitamin D Testing Market Attractiveness, by End-user, 2022-2031
  • Figure 104: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 105: Middle East & Africa Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 106: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 107: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 108: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2031
  • Figure 109: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
  • Figure 110: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 111: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 112: Middle East & Africa Vitamin D Testing Market Attractiveness, by Test Type, 2022-2031
  • Figure 113: Middle East & Africa Vitamin D Testing Market Attractiveness, by Technique, 2022-2031
  • Figure 114: Middle East & Africa Vitamin D Testing Market Attractiveness, by Patient Type, 2022-2031
  • Figure 115: Middle East & Africa Vitamin D Testing Market Attractiveness, by Indication, 2022-2031
  • Figure 116: Middle East & Africa Vitamin D Testing Market Attractiveness, by End-user, 2022-2031